Largest health care companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
UnitedHealth Group leads the 170 health care companies ranked by cash on hand, at HK$191B, ahead of Johnson & Johnson (HK$154.5B) and Centene (HK$140.2B). Figures as of 20 Nov 2026, 18:39 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupHK$191B
- Median
- HK$4.6B
- Combined market value
- HK$70.24T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Merit Medical SystemsMMSI · Health Care | HK$3.5B | HK$39.7B | HK$662.67 | 0.16% up | 3% down | ||
| 102 | STERISSTE · Health Care | HK$3.4B | HK$195B | HK$2,008.27 | 0.57% up | 3% down | ||
| 103 | Quest DiagnosticsDGX · Health Care | HK$3.3B | HK$225.3B | HK$2,047.69 | 0.83% up | 35% up | ||
| 104 | AlkermesALKS · Health Care | HK$3B | HK$60.5B | HK$360.04 | 0.53% down | 61% up | ||
| 105 | Revolution MedicinesRVMD · Health Care | HK$3B | HK$274.3B | HK$1,268.12 | 1.48% up | 125% up | ||
| 106 | Bausch + LombBLCO · Health Care | HK$3B | HK$55.3B | HK$154.68 | 4.62% down | 37% up | ||
| 107 | TeleflexTFX · Health Care | HK$3B | HK$50.7B | HK$1,277.29 | 0.27% down | 48% up | ||
| 108 | Guardant HealthGH · Health Care | HK$3B | HK$155.1B | HK$1,146.47 | 0.47% up | 38% up | ||
| 109 | Ionis PharmaceuticalsIONS · Health Care | HK$2.9B | HK$35.7B | HK$214.25 | 0.42% up | 64% down | ||
| 110 | AvantorAVTR · Health Care | HK$2.9B | HK$80.6B | HK$118.94 | 0.36% up | 31% up | ||
| 111 | Lantheus HoldingsLNTH · Health Care | HK$2.8B | HK$52.4B | HK$801.05 | 0.10% up | 83% up | ||
| 112 | Praxis Precision MedicinesPRAX · Health Care | HK$2.8B | HK$67.2B | HK$2,403.77 | 1.36% down | 83% up | ||
| 113 | Kymera TherapeuticsKYMR · Health Care | HK$2.8B | HK$77B | HK$901.96 | 3.61% down | 81% up | ||
| 114 | Belite BioBLTE · Health Care | HK$2.8B | HK$42B | HK$1,034.76 | 12.58% down | 25% up | ||
| 115 | CRISPR TherapeuticsCRSP · Health Care | HK$2.7B | HK$30.1B | HK$310.74 | 1.84% up | 22% down | ||
| 116 | Scholar Rock HoldingSRRK · Health Care | HK$2.5B | HK$47.1B | HK$385.87 | 2.26% down | 25% up | ||
| 117 | Axsome TherapeuticsAXSM · Health Care | HK$2.5B | HK$53.8B | HK$1,023.06 | 3.80% down | 9% down | ||
| 118 | HealthEquityHQY · Health Care | HK$2.5B | HK$62.7B | HK$757.86 | 0.71% down | 4% down | ||
| 119 | Cogent BiosciencesCOGT · Health Care | HK$2.4B | HK$37.1B | HK$213.00 | 2.04% down | 25% down | ||
| 120 | BrukerBRKR · Health Care | HK$2.3B | HK$70B | HK$458.45 | 5.81% down | 31% up | ||
| 121 | MiniMed GroupMMED · Health Care | HK$2.3B | HK$35.8B | HK$127.17 | 0.22% down | 12% down | ||
| 122 | Mirum PharmaceuticalsMIRM · Health Care | HK$2.3B | HK$49.7B | HK$761.90 | 1.77% up | 35% up | ||
| 123 | Amneal PharmaceuticalsAMRX · Health Care | HK$2.2B | HK$58.2B | HK$167.19 | 0.28% down | 79% up | ||
| 124 | Bio-TechneTECH · Health Care | HK$2.1B | HK$89.6B | HK$570.10 | 0.05% up | 18% up | ||
| 125 | Definium TherapeuticsDFTX · Health Care | HK$2B | HK$31B | HK$226.75 | 1.87% down | 176% up | ||
| 126 | GRAILGRAL · Health Care | HK$2B | HK$35.4B | HK$786.69 | 4.27% down | 12% up | ||
| 127 | LifeStance Health GroupLFST · Health Care | HK$1.9B | HK$40.8B | HK$107.26 | 2.59% up | 107% up | ||
| 128 | HaemoneticsHAE · Health Care | HK$1.9B | HK$43B | HK$944.22 | 0.08% up | 53% up | ||
| 129 | Option Care HealthOPCH · Health Care | HK$1.8B | HK$37.1B | HK$247.72 | 0.02% down | 7% up | ||
| 130 | Hims & Hers HealthHIMS · Health Care | HK$1.8B | HK$27.5B | HK$117.18 | 6.68% down | 54% down | ||
| 131 | Arrowhead PharmaceuticalsARWR · Health Care | HK$1.8B | HK$46.9B | HK$332.06 | 2.94% down | 8% up | ||
| 132 | Summit TherapeuticsSMMT · Health Care | HK$1.8B | HK$63.2B | HK$79.01 | 4.64% down | 35% down | ||
| 133 | Charles River Laboratories InternationalCRL · Health Care | HK$1.7B | HK$118.7B | HK$2,476.71 | 3.64% down | 96% up | ||
| 134 | Kodiak SciencesKOD · Health Care | HK$1.6B | HK$49.9B | HK$762.52 | 0.63% down | 371% up | ||
| 135 | Madrigal PharmaceuticalsMDGL · Health Care | HK$1.6B | HK$70.3B | HK$3,028.31 | 2.62% down | 28% down | ||
| 136 | PACS GroupPACS · Health Care | HK$1.5B | HK$55.1B | HK$346.91 | 2.86% up | 56% up | ||
| 137 | PenumbraPEN · Health Care | HK$1.5B | HK$98.8B | HK$2,507.94 | 0.01% down | 11% up | ||
| 138 | Twist BioscienceTWST · Health Care | HK$1.4B | HK$56B | HK$822.05 | 6.04% down | 291% up | ||
| 139 | IDEXX LaboratoriesIDXX · Health Care | HK$1.4B | HK$423.3B | HK$5,372.59 | 0.61% down | 5% down | ||
| 140 | Ligand PharmaceuticalsLGND · Health Care | HK$1.4B | HK$45B | HK$2,251.87 | 0.13% up | 44% up | ||
| 141 | VaxcytePCVX · Health Care | HK$1.4B | HK$69.7B | HK$440.42 | 3.72% down | 22% up | ||
| 142 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | HK$1.3B | HK$58B | HK$738.34 | 0.71% up | 125% up | ||
| 143 | MSA SafetyMSA · Health Care | HK$1.3B | HK$52.4B | HK$1,360.84 | 1.49% down | 13% up | ||
| 144 | Dr. Reddy's LaboratoriesRDY · Health Care | HK$1.3B | HK$97.5B | HK$116.90 | 0.57% up | 7% up | ||
| 145 | Henry ScheinHSIC · Health Care | HK$1.2B | HK$73.5B | HK$664.59 | 0.01% down | 16% up | ||
| 146 | Universal Health ServicesUHS · Health Care | HK$1.1B | HK$81.1B | HK$1,407.32 | 2.61% up | 25% down | ||
| 147 | Halozyme TherapeuticsHALO · Health Care | HK$1B | HK$83.1B | HK$728.63 | 0.09% down | 32% up | ||
| 148 | Protagonist TherapeuticsPTGX · Health Care | HK$1B | HK$62.8B | HK$962.71 | 0.96% down | 45% up | ||
| 149 | CytokineticsCYTK · Health Care | HK$960.3M | HK$56.2B | HK$403.35 | 0.00% | 21% down | ||
| 150 | Corcept TherapeuticsCORT · Health Care | HK$944.4M | HK$55.1B | HK$503.05 | 1.23% down | 16% down | ||
| 151 | Cooper CompaniesCOO · Health Care | HK$866.9M | HK$88.9B | HK$467.49 | 1.14% down | 20% down | ||
| 152 | Travere TherapeuticsTVTX · Health Care | HK$729.2M | HK$36.2B | HK$377.17 | 0.37% down | 39% up | ||
| 153 | GlaukosGKOS · Health Care | HK$711.8M | HK$110.4B | HK$1,865.57 | 0.04% down | 139% up | ||
| 154 | BrightSpring Health ServicesBTSG · Health Care | HK$692.6M | HK$98.2B | HK$493.64 | 1.62% down | 85% up | ||
| 155 | ImmunityBioIBRX · Health Care | HK$692.4M | HK$50.4B | HK$47.42 | 7.91% down | 216% up | ||
| 156 | Spyre TherapeuticsSYRE · Health Care | HK$671.9M | HK$70.2B | HK$739.68 | 3.34% down | 302% up | ||
| 157 | Concentra Group Holdings ParentCON · Health Care | HK$626.3M | HK$41.2B | HK$327.40 | 0.77% up | 105% up | ||
| 158 | TG TherapeuticsTGTX · Health Care | HK$620.4M | HK$76B | HK$502.81 | 1.13% down | 103% up | ||
| 159 | ChemedCHE · Health Care | HK$584.1M | HK$55.7B | HK$4,299.25 | 0.51% down | 25% up | ||
| 160 | ErascaERAS · Health Care | HK$578.5M | HK$38.6B | HK$110.05 | 1.27% down | 387% up | ||
| 161 | Encompass HealthEHC · Health Care | HK$565.9M | HK$103.4B | HK$1,053.90 | 1.65% up | 16% up | ||
| 162 | Adaptive BiotechnologiesADPT · Health Care | HK$552.5M | HK$35.5B | HK$219.23 | 0.29% down | 51% up | ||
| 163 | Mettler-Toledo InternationalMTD · Health Care | HK$524.3M | HK$262.8B | HK$13,214.44 | 1.16% down | 17% up | ||
| 164 | Edgewise TherapeuticsEWTX · Health Care | HK$479.3M | HK$34.5B | HK$315.40 | 2.26% down | 82% up | ||
| 165 | Rhythm PharmaceuticalsRYTM · Health Care | HK$425.6M | HK$61.6B | HK$888.44 | 2.95% down | 15% up | ||
| 166 | Dianthus TherapeuticsDNTH · Health Care | HK$400.4M | HK$37B | HK$656.20 | 1.31% down | 105% up | ||
| 167 | Oruka TherapeuticsORKA · Health Care | HK$367.9M | HK$49.9B | HK$736.31 | 3.72% down | 233% up | ||
| 168 | HeartflowHTFL · Health Care | HK$351M | HK$32.1B | HK$365.57 | 4.50% up | 45% up | ||
| 169 | CG OncologyCGON · Health Care | HK$254.7M | HK$56.4B | HK$631.81 | 1.58% down | 93% up | ||
| 170 | VeradermicsMANE · Health Care | HK$170.6M | HK$39.8B | HK$944.01 | 3.18% down | 230% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 7.8380 HKD).
Questions and answers
Which health care companies rank first by cash on hand?
UnitedHealth Group (HK$191B), Johnson & Johnson (HK$154.5B) and Centene (HK$140.2B) are the top three of the 170 health care companies ranked by cash on hand as of 20 Nov 2026, 18:39 UTC.
How many health care companies are in this ranking?
170 are ranked by cash on hand.
What are these health care companies worth together?
The 170 health care companies ranked by cash on hand have a combined market value of HK$70.24T as of 20 Nov 2026, 18:39 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by cash on hand”, data as of 20 November 2026. https://funkfolio.com/companies/sector/health-care?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.